KALA BIO, INC. Other Noncash Income (Expense)
KALA BIO, INC. (KALA) reported Other Noncash Income (Expense) of -$129.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-04-15
- KALA BIO, INC. other noncash income (expense) for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- KALA BIO, INC. other noncash income (expense) for the quarter ending 2024-09-30 was -$12.00K, a 100.28% decline year-over-year.
- KALA BIO, INC. other noncash income (expense) for the quarter ending 2024-06-30 was -$100.00K.
- KALA BIO, INC. other noncash income (expense) for the quarter ending 2024-03-31 was -$17.00K.
- KALA BIO, INC. other noncash income (expense) for fiscal 2024 was -$129.00K, a 102.98% decline from fiscal 2023.
- KALA BIO, INC. other noncash income (expense) for fiscal 2023 was $4.32M.
- KALA BIO, INC. other noncash income (expense) for fiscal 2022 was -$76.00K.
- KALA BIO, INC. other noncash income (expense) for fiscal 2021 was -$173.00K.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | -$12.00K derived: sum of 2 quarters · filed 2026-04-15 | -$112.00K derived: sum of 3 quarters · filed 2026-04-15 | -$129.00K 10-K · filed 2026-04-15 | |
| 2024-09-30 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-19 | -$112.00K derived: sum of 2 quarters · filed 2025-11-19 | -$129.00K 10-Q · filed 2025-11-19 | -$128.00K derived: sum of 4 quarters · filed 2025-11-19 | |
| 2024-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$117.00K 10-Q · filed 2025-08-08 | -$116.00K derived: sum of 3 quarters · filed 2025-08-08 | $4.16M derived: sum of 4 quarters · filed 2025-08-08 | |
| 2024-03-31 | -$17.00K 10-Q · filed 2025-05-14 | -$16.00K derived: sum of 2 quarters · filed 2025-05-14 | $4.26M derived: sum of 3 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $4.28M derived: sum of 2 quarters · filed 2025-03-31 | $4.32M 10-K · filed 2025-03-31 | ||
| 2023-09-30 | $4.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $4.32M 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | $47.00K 10-Q · filed 2024-08-06 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | -$103.00K derived: sum of 2 quarters · filed 2024-03-29 | -$78.00K derived: sum of 3 quarters · filed 2024-03-29 | -$76.00K 10-K · filed 2024-03-29 | |
| 2022-09-30 | -$103.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$78.00K derived: sum of 2 quarters · filed 2023-11-13 | -$76.00K 10-Q · filed 2023-11-13 | -$241.00K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $27.00K 10-Q · filed 2023-08-04 | -$138.00K derived: sum of 3 quarters · filed 2023-08-04 | -$124.00K derived: sum of 4 quarters · filed 2023-08-04 | |
| 2022-03-31 | $2.00K 10-Q · filed 2023-05-09 | -$163.00K derived: sum of 2 quarters · filed 2023-05-09 | -$149.00K derived: sum of 3 quarters · filed 2023-05-09 | -$161.00K derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | -$165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | -$151.00K derived: sum of 2 quarters · filed 2023-03-03 | -$163.00K derived: sum of 3 quarters · filed 2023-03-03 | -$173.00K 10-K · filed 2023-03-03 | -$151.00K 10-K · filed 2022-03-29 |
| 2021-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.00K derived: sum of 2 quarters · filed 2022-11-08 | -$8.00K 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | -$12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$22.00K 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | -$10.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |